Global Biosimilars Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Biosimilars Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Product Class (Monoclonal Antibodies, Recombinant Hormones, Immunomodulators, Anti-Inflammatory Agents, and Other Product Classes), Application (Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders, Oncology, and Other Applications), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Biosimilars Market was valued at USD 37,654.5 million in 2023 and is expected to reach USD 142,500.5 million by 2031 while growing at a CAGR of 18.1% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global Biosimilars market growth. Biosimilars, akin to their reference biologic medicines, maintain high similarity without clinically significant differences in safety, purity, and potency. Unlike generic drugs, which mirror their small-molecule references precisely, biosimilars diverge due to the complexity of biological molecules and current manufacturing technology constraints.
The biosimilars market is propelled by the growing demand for cost-effective treatment and increasing healthcare expenditure, yet hindered by clinical challenges and intellectual property issues.
Furthermore, the global Biosimilars industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Product Class Analysis
The Global Biosimilars Market is segmented among Monoclonal Antibodies, Recombinant Hormones, Immunomodulators, Anti-Inflammatory Agents, and Other Product Classes, based on Product Class. In 2023, Monoclonal Antibodies accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Application Analysis
The Global Biosimilars Market is segmented among Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders, Oncology, and Other Applications, based on Application. In 2023, Oncology accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Biosimilars Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Novartis AG, Pfizer Inc., Dr. Reddy's Laboratories Ltd, Amgen Inc., Eli Lily and Company, Coherus Biosciences, Inc., and Samsung Bioepies Co., Ltd
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Biosimilars Market Dynamics
Drivers
Restraints
Opportunity
4. Global Biosimilars Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Biosimilars Market Segmentation, By Product Class
Global Biosimilars Market Share Analysis, By Product Class
Global Biosimilars Market Growth Analysis, By Product Class
Global Biosimilars Market Trends, By Product Class
o Monoclonal Antibodies
o Recombinant Hormones
o Immunomodulators
o Anti-Inflammatory Agents
o Other Product Classes
6. Global Biosimilars Market Segmentation, By Application
Global Biosimilars Market Share Analysis, By Application
Global Biosimilars Market Growth Analysis, By Application
Global Biosimilars Market Trends, By Application
o Blood Disorders
o Growth Hormonal Deficiency
o Chronic and Autoimmune Disorders
o Oncology
o Other Applications
7. Global Biosimilars Market Segmentation, By Region
Global Biosimilars Market Share Analysis, By Region
Global Biosimilars Market Growth Analysis, By Region
Global Biosimilars Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
8. Competitive Landscape
Novartis AG*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Pfizer Inc.
Dr. Reddy's Laboratories Ltd
Amgen Inc.
Eli Lily and Company
Coherus Biosciences, Inc.
Samsung Bioepies Co., Ltd
*Similar analysis will be provided for each company listed above.